Gallery
Photos from events, contest for the best costume, videos from master classes.
 |  |
 |  |
 |  |
 |  |
 |  |
 |  |
Gabapentin readily enters the brain and prevents seizures in a number of animal models of epilepsy. Gabapentin does not possess affinity for either GABAA or GABAB receptor nor does it alter the metabolism of GABA. It does not bind to other neurotransmitter receptors of the brain and does not interact with sodium channels. Summary of Product Characteristics for Healthcare Professionals | Upjohn EESV The information for each product comes in the form of a Summary of Product Characteristics (SPC or SmPC) and Patient Information Leaflet (PIL) or Package Leaflet (PL), where relevant. These documents are approved by the medicines’ regulator ( HPRA or EMA ) as part of the process of authorising a medicine for sale or supply in Ireland. We would like to show you a description here but the site won’t allow us. Section 4.6 – Pregnancy- Risk related to gabapentin: Addition of “ Gabapentin crosses the human placenta.” Section 5.3 – Update to Teratogenesis data. Updated on 16 January 2018 Summary of Product Characteristics for Healthcare Professionals | Upjohn EESV Gabapentin is indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults and children aged 6 years and above (see section 5.1). Gabapentin 100mg, 300mg & 400mg Capsules info.ie@viatris.com; Summary of Product Characteristics for Healthcare Professionals | Gerard Laboratories. Gabapentin is indicated for the treatment of peripheral neuropathic pain such as painful diabetic neuropathy and post-herpetic neuralgia in adults. For oral use. Gabapentin can be given with or without food and should be swallowed whole with sufficient fluid-intake (e.g. a glass of water). Gabapentin. Medicine Status Monitoring SPC PIL XPIL Legal Category Active Ingredient(s) Company . Gabapentin 100mg, 300mg & 400mg Capsules. No Recent Update . Gabapentin *Additional information is available within the SPC or upon request to the company Scan the QR code or enter an email to access and share this medicine: Gabapentin readily enters the brain and prevents seizures in a number of animal models of epilepsy. Gabapentin does not possess affinity for either GABAA or GABAB receptor nor does it alter the metabolism of GABA. It does not bind to other neurotransmitter receptors of the brain and does not interact with sodium channels. It is written by pharmaceutical companies as a patient version of the Summary of Product Characteristics (SPC). Changes to the PIL after your medicine was packed may mean that the version on medicines.ie may differ from the version found with your medicine. Gabapentin is indicated as monotherapy in the treatment of partial seizures with and without secondary generalization in adults and adolescents aged 12 years and above. Treatment of peripheral neuropathic pain Gabapentin is indicated for the treatment of peripheral neuropathic pain such as painful diabetic neuropathy and post-herpetic neuralgia in adults. Download Gabin 100mg SPC & PIL here. Download Gabin 300mg SPC & PIL here. Download Gabin 400mg SPC & PIL here Gabapentin is a structural analogue of the neurotransmitter gamma-aminobutyric acid (GABA) (1,2) Gabapentin: The mechanism of action is unclear - it was designed as a GABA analogue but does not bind to GABA receptors (1); it may bind to calcium channels in the brain. Gabapentin 100mg, 300mg & 400mg Capsules info.ie@viatris.com; Summary of Product Characteristics for Healthcare Professionals | Gerard Laboratories. Gabapentin *Additional information is available within the SPC or upon request to the company info.ie@viatris.com; Medical Information Direct Line: +44(0) 1707 Child 6–11 years 10 mg/kg once daily (max. per dose 300 mg) on day 1, then 10 mg/kg twice daily (max. per dose 300 mg) on day 2, then 10 mg/kg 3 times a day (max. per dose 300 mg) on day 3; usual dose 25–35 mg/kg daily in 3 divided doses, some children may not tolerate daily increments; longer intervals (up to weekly) may be more appropriate, daily dose maximum to be given in 3 divided info.ie@viatris.com; Medical Information Direct Line: +44(0) 1707 853000 press 1; Summary of Product Characteristics for Healthcare Professionals | Upjohn EESV
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
| |
| |
| |
| |
| |
| |